PT-141
PT-141 (Bremelanotide) is a synthetic cyclic heptapeptide derived from Melanotan-2, designed to selectively engage central melanocortin receptors MC3R and MC4R in the hypothalamic region. Supplied as a lyophilized powder in a 3mL vial, it is intended exclusively for in vitro laboratory research by qualified scientific personnel.
This peptide has been utilized in preclinical studies examining MC3R and MC4R receptor binding kinetics, hypothalamic melanocortin signaling pathways, CNS neuropeptide pathway interactions, and central receptor selectivity profiles in isolated cell models — independent of the broader neurological effects associated with endogenous melanocortin activity.
Product Details
- Form: Lyophilized powder (for laboratory research)
- Amount: 10 mg per vial
- Purity: ≥ 98% (HPLC tested)
- Sequence: Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH (7 amino acids, cyclic analogue)
- Molecular Formula: C₅₀H₆₈N₁₄O₁₀
- Molecular Weight: ~1025.2 g/mol
- Intended Use: Laboratory research only
DISCLAIMER: This product is strictly to be used for scientific research use only. It is not for human consumption and the FDA has not approved the use for diagnostic, therapeutic, or medical purposes.
We recommend you review our Terms of Service if you have questions about product use.
